Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort

A. Gouveia Cardoso (Porto, Portugal), L. Mendonça Almeida (Porto, Portugal), A. Fernandes (Porto, Portugal), B. Lima (Porto, Portugal), I. Neves (Porto, Portugal), H. Novais Bastos (Porto, Portugal), P. Caetano Mota (Porto, Portugal), N. Melo (Porto, Portugal), C. Souto Moura (Porto, Portugal), S. Guimarães (Porto, Portugal), A. Carvalho (Porto, Portugal), R. Cunha (Porto, Portugal), J. Pereira (Porto, Portugal), A. Morais (Porto, Portugal)

Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Gouveia Cardoso (Porto, Portugal), L. Mendonça Almeida (Porto, Portugal), A. Fernandes (Porto, Portugal), B. Lima (Porto, Portugal), I. Neves (Porto, Portugal), H. Novais Bastos (Porto, Portugal), P. Caetano Mota (Porto, Portugal), N. Melo (Porto, Portugal), C. Souto Moura (Porto, Portugal), S. Guimarães (Porto, Portugal), A. Carvalho (Porto, Portugal), R. Cunha (Porto, Portugal), J. Pereira (Porto, Portugal), A. Morais (Porto, Portugal). Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort. 2249

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: A population-based study
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018




Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
Source: ERJ Open Res, 5 (4) 00259-2018; 10.1183/23120541.00259-2018
Year: 2019



Criteria for PF-ILD in a cohort of patients with chronic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Pulmonary function trends predict mortality in patients with hypersensitivity pneumonitis
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018



Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018



Mortality and survival predictor in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017

Risk factors for respiratory failure in patients with COVID-19 pneumonitis: A retrospective study
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021


Risk factors for postoperative acute exacerbation of interstitial lung diseases: a matched case-control study
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019



Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018

Incidence and risk factors of chronic airway obstruction (ACOS) in a population-based asthma cohort
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017

Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019



Severe pulmonary sarcoidosis: definition and risk stratification
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020


Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019




Is anemia associated with readmission risk in severe acute exacerbation of COPD: Preliminary results from a naturalistic cohort
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020


Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011